Date:10/30/2008

and Orchid Cellmark's ability to successfully offer its services directly to U.K. police forces. These risks and other additional factors affecting these forward-looking statements and Orchid Cellmark's business are discussed under the headings "Risks Related to Our Business" and "Risks Associated with Our Common Stock" in Orchid Cellmark's Annual Report on Form 10-K for the year ended December 31, 2007, as filed with the Securities and Exchange Commission, and in other filings made by Orchid Cellmark with the Securities and Exchange Commission from time to time. Orchid Cellmark expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward- looking statements contained herein to reflect any change in Orchid Cellmark's expectations with regard thereto or any change in events, conditions, or circumstances on which any such statements are based, except as may be required by law.

Information contained in our press releases should be considered accurate only as of the date of the release. Information in any press release may be superseded by more recent information we have disclosed in later press releases, filings with the Securities and Exchange Commission or otherwise. Press releases may contain forward-looking statements based on the expectations of our management as of the date of the release. Actual results may materially differ based on several factors, including those described in the press release.

Contact:

Investors: Media:

Mary Bashore Rick Anderson

Orchid Cellmark Inc. The Torrenzano Group

(609) 750-2324 (212) 681-1700

ir@orchid.com randerson@torrenzano.com

Orchid Cellmark Inc. and Subsidiaries

Condensed Consolidated Statements of Operations<
'/>"/>

SOURCE Orchid Cellmark Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8
Related medicine news :

1. Orchid Cellmark Reports Second Quarter 2008 Financial Results
2. Orchid Cellmark To Announce Second Quarter 2008 Financial Results on July 31, 2008
3. Orchid Cellmark Reports First Quarter 2008 Financial Results
4. Orchid Cellmark to Open a New Forensic Facility in the United Kingdom to Meet Increasing Demand for Its Services
5. Orchid Cellmark Reports Fourth Quarter and Full Year 2007 Financial Results
6. Orchid Cellmark to Announce Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
7. Orchid Cellmark Appoints William J. Thomas Vice President and General Counsel
8. Orchid Cellmark Reports Third Quarter 2007 Financial Results
9. ISTA Pharmaceuticals Reports Third Quarter 2008 Financial Results
10. Gentiva Reports Third Quarter Revenue and Profit Growth
11. LegalView Reports on Rare Traumatic Brain Injury Condition That Could Cause Complete Paralysis of A Victim